Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Robeson

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Medical Physics|November 1, 1981
Performance of a refrigerated charcoal trap for xenon-133M Powell, R Grando, W Robeson
Clinical Nuclear Medicine|March 1, 1985
Early detection of anthracycline-induced cardiotoxicity by stress radionuclide cineangiography in conjunction with Fourier amplitude and phase analysisK E Alcan, W Robeson, M C Graham, et al.
Radiology|July 1, 1993
Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curveS Takikawa, V Dhawan, P Spetsieris, et al.
Clinical Nuclear Medicine|June 1, 1984
Fourier amplitude and phase analysis in the clinical evaluation of patients with cardiomyopathyK E Alcan, W Robeson, M C Graham, et al.
Clinical Nuclear Medicine|June 1, 1984
A clinical evaluation of the RNCA study using Fourier filtering as a preprocessing methodW Robeson, K E Alcan, M C Graham, et al.
Clinical Nuclear Medicine|December 1, 1984
Combined Fourier amplitude and phase imaging in patients with coronary artery diseaseK E Alcan, W Robeson, M C Graham, et al.
Nuclear Medicine Communications|February 1, 1992
The use of a new radiopharmaceutical, 97Ru-DISIDA, and of 99Tcm-sulphur colloid for the simultaneous evaluation of duodenogastric reflux and gastric emptyingI Zanzi, J Markowitz, S C Srivastava, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1994
Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlationsS Takikawa, V Dhawan, T Chaly, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1996
Combined FDOPA and 3OMFD PET studies in Parkinson's diseaseV Dhawan, T Ishikawa, C Patlak, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
A new cholescintigraphic agent: ruthenium-97-DISIDAI Zanzi, S C Srivastava, G E Meinken, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Medical Physics|November 1, 1981
Performance of a refrigerated charcoal trap for xenon-133M Powell, R Grando, W Robeson
Clinical Nuclear Medicine|March 1, 1985
Early detection of anthracycline-induced cardiotoxicity by stress radionuclide cineangiography in conjunction with Fourier amplitude and phase analysisK E Alcan, W Robeson, M C Graham, et al.
Radiology|July 1, 1993
Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curveS Takikawa, V Dhawan, P Spetsieris, et al.
Clinical Nuclear Medicine|June 1, 1984
Fourier amplitude and phase analysis in the clinical evaluation of patients with cardiomyopathyK E Alcan, W Robeson, M C Graham, et al.
Clinical Nuclear Medicine|June 1, 1984
A clinical evaluation of the RNCA study using Fourier filtering as a preprocessing methodW Robeson, K E Alcan, M C Graham, et al.
Clinical Nuclear Medicine|December 1, 1984
Combined Fourier amplitude and phase imaging in patients with coronary artery diseaseK E Alcan, W Robeson, M C Graham, et al.
Nuclear Medicine Communications|February 1, 1992
The use of a new radiopharmaceutical, 97Ru-DISIDA, and of 99Tcm-sulphur colloid for the simultaneous evaluation of duodenogastric reflux and gastric emptyingI Zanzi, J Markowitz, S C Srivastava, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1994
Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlationsS Takikawa, V Dhawan, T Chaly, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1996
Combined FDOPA and 3OMFD PET studies in Parkinson's diseaseV Dhawan, T Ishikawa, C Patlak, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
A new cholescintigraphic agent: ruthenium-97-DISIDAI Zanzi, S C Srivastava, G E Meinken, et al.
Pageof 2